ArticleBrain research2025
Regulation of LRRK2 activity by metabolic stress and heavy metal exposure.
Article in Brain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Genetic variability in the gene encoding leucine-rich repeat kinase 2 (LRRK2) is associated with both familial and sporadic Parkinson's disease (PD). While LRRK2 is known to modulate vesicular trafficking and stress signaling through its phosphorylation and kinase activity, how it responds to metabolic and environmental stressors remains poorly understood. Here, we show that acute inhibition of glycolysis and oxidative phosphorylation triggers rapid, reversible dephosphorylation of LRRK2 at constitutive sites in cells, ex vivo brain slices, and primary astrocytes. In contrast, glucose deprivation modestly increases LRRK2 kinase activity and Rab substrate phosphorylation. In vivo, chronic 2-deoxyglucose treatment reduces S935 phosphorylation in kidney tissue, linking energy stress to LRRK2 modulation in peripheral organs. Strikingly, manganese (Mn), a PD-relevant environmental toxicant, robustly activates LRRK2, inducing pS1292 autophosphorylation and phosphorylation of Rab8a, Rab10 and Rab12, while suppressing S935 phosphorylation after a 24 hrs exposure. Time-resolved analysis revealed distinct temporal substrate regulation, with rapid Rab12 phosphorylation and pRab10 levels gradually increasing and peaking only after 24 h. Phosphorylated Rab10 remains closely associated with both lysosomal and centrosomal membranes under Mn stress. Mn impaired mitochondrial respiration and increased ROS, and antioxidant treatment rescued Rab10 phosphorylation, establishing a redox-dependent mechanism of LRRK2 activation. Together, these findings reveal stressor-specific modes of LRRK2 regulation and suggest that LRRK2 integrates metabolic and environmental signals via redox-sensitive pathways relevant to PD pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.